Senzar Asset Management as of Sept. 30, 2017
Portfolio Holdings for Senzar Asset Management
Senzar Asset Management holds 28 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Halozyme Therapeutics (HALO) | 16.2 | $67M | 3.8M | 17.37 | |
| Sanofi-Aventis SA (SNY) | 9.7 | $40M | 798k | 49.79 | |
| Regeneron Pharmaceuticals (REGN) | 8.4 | $35M | 77k | 446.96 | |
| Allergan Plc pfd conv ser a | 7.8 | $32M | 44k | 737.69 | |
| Tesaro | 6.9 | $28M | 220k | 129.08 | |
| EXACT Sciences Corporation (EXAS) | 6.6 | $27M | 658k | 41.13 | |
| Anthem (ELV) | 5.9 | $24M | 127k | 190.00 | |
| Healthsouth | 5.2 | $21M | 460k | 46.35 | |
| Allergan | 3.0 | $12M | 60k | 204.71 | |
| Aerie Pharmaceuticals | 2.7 | $11M | 231k | 48.60 | |
| Tg Therapeutics (TGTX) | 2.5 | $10M | 864k | 11.85 | |
| Globus Med Inc cl a (GMED) | 2.4 | $9.8M | 329k | 29.69 | |
| Medtronic (MDT) | 2.3 | $9.6M | 123k | 77.78 | |
| Clovis Oncology | 2.3 | $9.3M | 112k | 82.35 | |
| Ironwood Pharmaceuticals (IRWD) | 2.0 | $8.0M | 507k | 15.80 | |
| Alder Biopharmaceuticals | 1.9 | $7.9M | 641k | 12.25 | |
| Insmed (INSM) | 1.8 | $7.4M | 239k | 31.14 | |
| Express Scripts Holding | 1.7 | $6.9M | 109k | 63.33 | |
| Universal Health Services (UHS) | 1.7 | $6.8M | 61k | 110.94 | |
| Mednax (MD) | 1.6 | $6.6M | 153k | 43.11 | |
| Theravance Biopharma (TBPH) | 1.5 | $6.2M | 182k | 34.15 | |
| Concert Pharmaceuticals I equity | 1.2 | $4.9M | 335k | 14.75 | |
| Corium Intl | 1.2 | $4.9M | 445k | 11.10 | |
| Endologix | 1.0 | $4.0M | 902k | 4.45 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $3.9M | 221k | 17.67 | |
| Foamix Pharmaceuticals | 0.6 | $2.6M | 463k | 5.58 | |
| Sientra | 0.5 | $2.0M | 130k | 15.53 | |
| Inotek Pharmaceuticals | 0.3 | $1.4M | 782k | 1.78 |
